EPC will showcase abstract presentations from pulmonologists and fellows-in-training. We invite you to participate by submitting your clinical research for review by our Abstract Committee. When preparing your abstract, organize it into a statement of purpose, statement of methods, and summary of results in sufficient detail to support the conclusion reached.
If your abstract is accepted for the conference, you will be assigned a specific day (Friday or Saturday) to present your findings.
All abstracts will will have the option to be published in the Journal of Precision Respiratory Medicine.
Abstract Submission Deadline
Monday, July 20, 2026
Abstract Submission Form
Coming soon
Abstract Fees
Coming soon
Abstract instructions:
- Size for poster display: 4 feet high by 6 feet long
- The abstract must adequately describe the objectives, methods, results, and conclusions so that the Abstract Committee may evaluate the quality of the work and proposed presentation.
- The abstract title should fully reflect the content of the abstract body.
- A structured abstract format is required:
o Title
o Author line (affiliations will not be printed in program booklet)
o Introduction (background and purpose of the project/study)
o Methods (study design, techniques)
o Results (summary of data)
o Conclusions
o Funding if appropriate
- Illustrations and tables will not be printed in the program booklet but may be included in your presentation poster.
- Supplementary data is not accepted under any circumstances.
- Abbreviations may be used in the abstract if such abbreviations are defined at their first mention.
- The abstract length is limited to 300 words.
- Abstracts must be submitted in a word.DOC format.
- Font size 12, New Times Roman, title and headings only in bold
- Authors are to be listed by First name, Last name, Highest degree (ie: John Smith, MD). Affiliations should not be included as they will not be printed in the program guide, but they are allowed in your final abstract presentation.
- Authors are encouraged, but not required, to submit for peer review and publication, any subsequent full-length manuscripts which derive from the submitted abstract.
- Each abstract submission must specify a corresponding author, to whom all correspondence about the abstract will be directed.
- The presenter of each accepted abstract must register for EPC.
- Wherever possible, non-commercial (generic) names must be used in all abstracts and posters. The Abstract Committee may request a revised submission of the abstract to enforce compliance with this ACCME requirement.
- All authors must agree to disclose all non-FDA approved use of FDA approved drugs in the submission email only. No further disclosure is needed.
- The authors must accept sole responsibility for the statements in their submitted abstract.